Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lymphocyte cytotoxicity for autologous hepatocytes.

Literature DB >> 6607192

Lymphocyte cytotoxicity for autologous hepatocytes.

M Mondelli, A L Eddleston.

Abstract

Entities: Disease

Mesh：

Year: 1984 PMID： 6607192 PMCID： PMC1432268 DOI： 10.1136/gut.25.2.109

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

27 in total

1. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors: A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal: Nature Date: 1974-12-20 Impact factor: 49.962

2. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors: R M Zinkernagel; P C Doherty
Journal: Nature Date: 1974-04-19 Impact factor: 49.962

3. A microassay for cell-mediated immunity.

Authors: M Takasugi; E Klein
Journal: Transplantation Date: 1970-03 Impact factor: 4.939

4. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors: A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal: Lancet Date: 1976-02-28 Impact factor: 79.321

5. Tumour cell lines induce interferon in human lymphocytes.

Authors: G Trinchieri; D Santoli; B B Knowles
Journal: Nature Date: 1977-12-15 Impact factor: 49.962

6. Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.

Authors: A P Geubel; R H Keller; W H Summerskill; E R Dickson; T B Tomasi; R G Shorter
Journal: Gastroenterology Date: 1976-09 Impact factor: 22.682

7. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

Authors: J M Vierling; D L Nelson; W Strober; D M Bundy; E A Jones
Journal: J Clin Invest Date: 1977-11 Impact factor: 14.808

2. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.

Authors: D H Van Thiel; H Wright; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; J McMichael; W Irish; T E Starzl
Journal: Am J Gastroenterol Date: 1995-05 Impact factor: 10.864

2 in total

Lymphocyte cytotoxicity for autologous hepatocytes.

1. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

2. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

3. A microassay for cell-mediated immunity.

4. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

5. Tumour cell lines induce interferon in human lymphocytes.

6. Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.

7. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

8. Cell-mediated immunity in acute and chronic hepatitis.

9. Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis.

10. Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes.

1. Cellular cytotoxicity against autologous hepatocytes in children with different forms of chronic hepatitis B.

2. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.